首页 | 本学科首页   官方微博 | 高级检索  
     

协同刺激分子B7-H3在重症肌无力患者外周血中的表达
引用本文:蒋觉安,薛群,刘翠平,高犁,张光波,陈永井,张学光. 协同刺激分子B7-H3在重症肌无力患者外周血中的表达[J]. 细胞与分子免疫学杂志, 2012, 28(8): 856-859
作者姓名:蒋觉安  薛群  刘翠平  高犁  张光波  陈永井  张学光
作者单位:1. 苏州大学附属第一医院特需病区,江苏苏州,215006
2. 苏州大学附属第一医院神经内科,江苏苏州,215006
3. 苏州大学医学生物技术研究所,江苏苏州,215007
基金项目:国家自然科学基金,江苏省普通高校研究生科研创新计划项目,江苏省卫生厅科技项目
摘    要:目的:检测重症肌无力(MG)患者外周血中协同刺激分子B7-H3的表达,并探讨其临床意义。方法:收集35例MG患者和44例健康对照(HC)外周血标本,采用免疫荧光标记,流式细胞检测外周血单个核细胞模型B7-H3(mB7-H3)的表达,ELISA法检测MG和HC血浆中可溶性B7-H3(sB7-H3)的含量。结果:MG患者外周血T淋巴细胞、单核细胞和B淋巴细胞上mB7-H3低水平表达,与HC无差异;MG患者外周血sB7-H3浓度为(2.166±0.958)ng/mL,显著低于HC(3.379±0.768)ng/mL;全身型MG(GMG)sB7-H3的浓度为(1.664±0.699)ng/mL,低于眼肌型MG(OMG)(2.396±0.985)ng/mL;并发胸腺异常的MG sB7-H3浓度为(1.593±0.441)ng/mL,低于胸腺正常MG(2.364±1.014)ng/mL;MGsB7-H3含量与QMGS评分呈负相关(r=-0.4189,P=0.012);免疫细胞mB7-H3与血浆sB7-H3无相关性。结论:MG患者sB7-H3表达下调,与疾病严重程度相关;在不同病理类型MG患者体内存在差异性表达,提示该分子可能参与了MG的免疫病理进程。

关 键 词:重症肌无力  B7-H3  自身反应性T细胞  免疫调控

Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients
JIANG Jue-an , XUE Qun , LIU Cui-ping , GAO Li , ZHANG Guang-bo , CHEN Yong-jing , ZHANG Xue-guang. Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients[J]. Chinese journal of cellular and molecular immunology, 2012, 28(8): 856-859
Authors:JIANG Jue-an    XUE Qun    LIU Cui-ping    GAO Li    ZHANG Guang-bo    CHEN Yong-jing    ZHANG Xue-guang
Affiliation:Department of Special Requirements Ward, First Affiliated Hospital, Soochow University, Suzhou 215006, China.
Abstract:AIM: To reveal the clinical significance of B7-H3 costimulatory molecule in myasthenia gravis(MG) patients by analyzing membranous B7-H3(mB7-H3) and soluble B7-H3(sB7-H3) expressions.METHODS: We collected peripheral blood samples of 35 MG patients and 44 health controls(HC) and detected the expression of mB7-H3 on peripheral blood mononuclear cells(PBMCs) using flow cytometry.ELISA was performed to analyze the levels of sB7-H3 in plasma samples from MG patients and HC.RESULTS: There was no significant difference in the expressions of mB7-H3 on T lymphocytes,monocytes or B cells between MG patients and HC.However,the level of sB7-H3 from MG patients was(2.166±0.958) ng/mL,significantly lower than that from HC(3.379±0.768) ng/mL.The level of sB7-H3 in general MG(GMG) patients(1.664±0.699) ng/mL was lower than that in ocular MG(OMG) patients(2.396±0.985) ng/mL.In MG patients complicated with abnormal thymus,the level of sB7-H3 was(1.593±0.441) ng/mL,also lower than that in MG patients with normal thymus(2.364±1.014) ng/mL.In addition,a significant negative correlation was found between the levels of sB7-H3 and QMGS in MG patients(r=-0.4189,P=0.012),but sB7-H3 was not associated with mB7-H3 in MG patients.CONCLUSION: In MG patients,down-regulation of sB7-H3 is finely correlated to the severity of the disease.Its different expression levels in various types of MG patients indicate that this costimulatory molecule may be involved in the immunopathogenesis of MG.
Keywords:myasthenia gravis  B7-H3  autoreactive T cell  immunoregulation
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号